SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-011412
Filing Date
2020-03-17
Accepted
2020-03-17 16:18:35
Documents
3
Period of Report
2020-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngm-8k_20200317.htm 8-K 37718
2 EX-99.1 ngm-ex991_6.htm EX-99.1 264443
3 GRAPHIC gb2ccdxtlcyr000001.jpg GRAPHIC 4434
  Complete submission text file 0001564590-20-011412.txt   309551
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38853 | Film No.: 20721203
SIC: 2834 Pharmaceutical Preparations